Substituted pyrido[3,2-d]pyrimidines for treating cancer

US9440968B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Bayard R. Huck · Sudbury, US
• Ruoxi Lan · Waltham, US
• Justin Potnick · Acton, US
• Lizbeth Celeste Deselm · Melrose, US
• Mark Cronin · Cambridge, US
• Constantin Neagu · Belmont, US
• Xiaoling Chen · Sharon, US
• Roch Boivin · North Chelmsford, US
• Theresa L. Johnson · Salem, US
• Andreas Goutopoulos · Boston, US

Key dates

• Filing date: Nov 27, 2013
• Grant date: Sep 13, 2016
• Expiry date: Nov 27, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel azaquinazoline carboxamide derivatives of formula (I)wherein W1, W2, W3, W4, R1, R2, R3 and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.